NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Quality Index
NewAmsterdam Pharma Company N.V. Ordinary Shares cash flow quality index. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Quality Index of -0.83x as of September 2025. Operating cash flow of $-32.77 Million is below net income of $39.53 Million, suggesting accrual-heavy earnings not yet converted to cash. See NAMS FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Quality Index by Year (None–None)
NewAmsterdam Pharma Company N.V. Ordinary Shares cash flow quality index by year from None to None. Year-by-year earnings quality comparison for NewAmsterdam Pharma Company N.V. Ordinary Shares. For the full cash flow conversion analysis, see NAMS cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|